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Introduction
Unluckily metastatic disease to bone which 
is mainly affect the axial skeleton (vertebral body, iliac 
bone, the proximal femora, and humeri) is a common 
squeal in many cancers as early or late presentation 
of the disease [1]. The presence of marrow metastasis 
has a great effect on the treatment plan, because its 
development was considered Stage IV, and here, only 
palliative treatment will be used in most cases [2]. 
Once bone metastasis occurs that there is dispersed 
morbidity from the neurological or stability problems 
and limitation of patient life from severe pain [3].
For that the characterization of the bony lesion 
in patients with primary malignancy is very important, 
this is broadly done using magnetic resonance imaging 
(MRI), the conventional MRI can detect the lesion and 
delineate it clearly from nearby normal marrow, but has 
limitation in predicting whether this lesion is benign or 
malignant [4] so the introduction of functional MRI that 
includes apparent diffusion coefficient (ADC) maps 
and diffusion-weighted imaging (DWI) can do this job 
and predict the nature of the lesion, especially when 
calculating the ADC value of the lesion [5].
Primarily, the DWI was established in the 
imaging of the central nervous system’s abnormalities [6]. 
With time, this MRI sequence has been used for variable 
body systems and examinations, mainly in the oncology 
patients [7].
Regarding our research, we focus the light on 
the appearance of variable bony lesions affecting the 
spine, some of them are common and are not neoplastic 
as typical hemangioma; here, the diagnosis is straight 
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forward while others are problematic as atypical 
hemangioma which leads to diagnostic dilemma in 
differentiating it from bony Mets [8].
The main principle of DWI technique is the 
regulations of free water transport in the cellular 
compartment, according to Brownian motion(9), by 
that DWI able to detect abnormal tissue by assessing 
the quantity of water within, the more compacted cells, 
the more limiting to water particles movement when 
compared with normal nearby tissues, this is opposing 
to the tissues with low cellular content or necrotic where 
disturbed cell membranes are predominant, diffusion is 
not restricted [10].
DWI is a spin-echo T2-weighted single-shot 
sequence that originates from two symmetric 
motion gradient pulses about a 180° refocusing 
pulse, so the moving water particles do not realign and 
exhibit a signal drop on DWI, while the water molecules 
interposed by cellular membranes or intracellular 
component gain the signal and show high signal on 
DWI [11].
DWI and ADC values have been offered for the 
discernment between the malignant deposit, especially 
in patients with primary condition [12], in general, the 
bone marrow metastases appear as a high signal area 
on DWI within low signal normal vertebral marrow, 
while in ADC, it appears as low signal within relatively 
high signal normal vertebral marrow [13].
Materials and Methods
This study included 80 patients referred to 
magnetic resonance (MR) unit from the oncology 
department in oncology teaching hospital – Medical City, 
Baghdad, Iraq, during the period from the beginning of 
September 3, 2019- July 7,2019.
All patients had a history of primary malignant 
tumor outside the bone marrow and complaining of back 
pain or symptoms related to spinal cord compression 
or having neurological deficit, those patients then 
subjected MRI examination of the spine, including the 
lumbar or thoracolumbar areas, using Avanto 1.5T 
closed MRI system Siemens (Germany).
The MRI protocols include sagittal T1-weighted 
(T1W) spin echo (SE), sagittal T2-weighted (T2W) SE, 
sagittal T2W fat suppression SE, and axial T2W SE.
After that, the DWIs were taken in the sagittal 
plane using a single-shot echo-planar sequence. The 
b values were 0, 500, and 800 s/mm2. DWIs were also 
obtained in sagittal plane.
After obtaining these images, full analysis of 
pathological findings was done by reviewing the T1 and 
T2 images and doing three-dimensional references 
to allocated the position of the lesion in ADC and DW 
sequences, the signal of the lesion is recorded in all 
sequences, and the brightness of the suspicious lesion 
is seen on DW and its ADC value was calculated.
Diagnosis of metastasis is established either 
by biopsy or radioisotope using bone scan or positron 
emitting tomography, all these with Mets had follow-up 
by repeating the MRI examination 3–6 months after 
initiation of chemo- or radiotherapy.
Statistical analysis
All the relevant data were entered using 
computerized statistical software; Statistical Package 
for the Social 
Sciences (SPSS) version 20. Descriptive 
statistics presented as mean ± standard deviation and 
frequencies as percentages.
Results
This is a cross-sectional study which 
includes 80 patients and four of them had follow-up 
study, 22 of them are cancer-free patients referred to 
MRI because of lower back pain, and the remaining 
58 patients had primary cancer outside the spine and 
also referred complaining of back pain and worry 
from metastasis.
The study samples consist of 55 females 
and 25 males, the breast cancer is the main primary 
in females and represents 29/58 patients, while 
the prostate cancer is the main cancer in male and 
represents 6/58 patients. Details of age, gender, and 
cancer types are illustrated in Table 1.
The MR examination in the control group is 
normal in 18/22 patients, the remaining four reveal 
Table 1: Age, gender, and cancer types of the study population
Age groups Number (%)
Age
<40 years 14 (17.5)
41–49 15 (18.75)
50–59 21 (26.25)
60–69 22 (27.5)
>70 8 (10)
Total 80 (100)
Gender
Males 25 (31.25)
Females 55 (68.75)
Total 80 (100)
Cancer type
Females
Breast 29 (72.5) 
Ovary 3 (7.5)
Uterus 3 (7.5)
Other 5 (12.5)
Total 40 (100)
Males 
Prostate 6 (46)
Lung 2 (15.5)
Other 5 (38.5)
Total 13(100)
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typical hemangioma in two, atypical hemangioma in 
one, and Modic I end plate changes in the last one.
While the examination of the patients with 
primary cancer reveals metastasis in 14/58, the 
remaining findings are discussed briefly in Table 2.
Table 2: MRI findings in control group and cancer patients
MRI findings Number (%)
Control group
Normal
Typical hemangioma 
Modic I 
Atypical hemangioma
18 (81.8)
2 (9.1)
1 (4.54)
1 (4.54)
Total 22 (100)
Patients
Metastasis 
Free of metastasis
Inactive
Typical and atypical hemangioma 
Modic changes
Fracture
Collection
Others 
14 (24.1)
17 (29.3)
9 (15.5)
7 (12.06)
3 (5.17)
5 (8.6)
1 (1.7)
2 (3.4)
Total 58 (100)
MRI: Magnetic resonance imaging.
The correlation between T1W images and 
Fatsat sequence, on the one hand, with DWI results, on 
the other hand, in cases of malignant findings revealed 
that low signal lesions on T1, and high Fatsat and DWI 
seen in 23/58 (39.6%) of those only 10 (17%) patients 
are really metastasis, while when adding the low ADC 
value (< 9 × 10−3 mm2/s) to previous parameters, the 
metastasis percentage decreases from 39.6% to 22.4% 
(13/58).
The sensitivity, specificity, positive predictive 
value (PPV), negative predictive value (NPV) and 
overall accuracy of ADC in detecting metastasis within 
the vertebral marrow are illustrated in Table 3.
Table 3: Sensitivity, specificity, positive predictive and 
negative value, and overall accuracy of ADC in detecting 
metastasis
ADC value Metastasis present Metastasis absent Total 
Low 16/84* 2/84* 18
Normal or high 1/84* 39/84* 40
Total 17 41
*The total number of patients increased to 84 because four of the patients had two pathology, 1st is patient with 
Ewing sarcoma and had collection (abscess as well), two patients are the elderly with prostate cancer and had 
active and inert bony lesion, and finally, a patient with breast cancer and also had active and inert lesion.
Value (%) 95% confidence interval (CI)
Sensitivity 94.12 71.31–99.85
Specificity 95.12 83.47–99.40
PPV 88.89 67.32–96.88
NPV 97.50 85.33–99.62
Accuracy 94.83 85.62–98.92
ADC: Apparent diffusion coefficient, PPV: Positive predictive value, NPV: Negative predictive value.
Discussion
The introduction of diffusion-weighted MRI 
revolutionized the diagnosis of benign and malignant 
vertebral tumors in addition being non-invasive 
technique, this was achieved by considering the low 
signal lesion as benign and the high signal one as 
malignant, on the other hand, the high signal on ADC is 
more in keeping with a benign cause [14].
Before the DWI was introduced, it was difficult 
to diagnose the lesion, whether being metastatic 
or benign tumors using the T1W and T2W images 
and even with using the fat saturation sequence, the 
latter only highlighting the hidden lesion that could not 
clearly visualized in the T1W and T2W sequences. The 
intravenous contrast injection did not add anything to 
the diagnosis because many numbers of benign lesions 
took the contrast and by that, it was not solving this 
problem.
Figure 1: 55 years age female patient with history of breast cancer 
her MRI reveals (a) ADC image shows low signal in 4th and 5th 
lumber vertebral bodies (arrows )ADC ( 6x10-3 mm2 / sec) (b) DWI 
image shows restricted signal within the corresponding vertebral 
body ( 800s/mm2)-histopathology diagnosis
a b
However, after the entry of the ADC and the 
DW sequences, the problem was nearly solved, so 
when the lesion appeared of high signal on DWI, we 
compare that to it to corresponding ADC signal, if it is 
high on DWI and low on ADC, this raises the suspicious 
of malignant tumor.
Figure 2: 35 years age female patient with history of Ewing sarcoma, 
her MRI reveals paravertebral abscess (a) ADC sagittal image shows 
low signal rim collection around 5th lumber and 1st sacral vertebral 
bodies (arrows) with ADC ( 3x10-3 mm2 / sec) (b) DWI:restricted 
signal within the rim of collection .
a b
In addition to the role of ADC mainly in 
the follow-up of cancer cases after treatment with 
chemotherapy, radiotherapy, or hormonal therapy, the 
response will be indicated by changing the low ADC 
value to high while the DWI signal either still high or 
reverse to low.
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In our study, the ADC value in detection bony 
metastasis shows high sensitivity of 94%, specificity of 
95%, and overall accuracy of 94% and this nearly in line 
with a study done by Tadros and Louka [15].
In 2016, a study showed that a sensitivity of 
99%, a specificity of 98%, a PPV of 98%, a NPV of 
96%, and an accuracy of 98% for the detection of bone 
metastatic deposits, and this is highly comparable to 
the results in our study [16].
Regarding the PPV and NPV of ADC value in 
detection of vertebral marrow secondary was 89% and 
97% and these in concordance with a study done by 
Gong et al. [17].
Conclusion
1. Conventional MRI using standard T1W, 
T2W, and fat suppression sequences cannot 
discriminate between benign and pathological 
vertebral marrow lesions.
2. Using DWI improves the recognition 
of pathological bony lesion and this is 
strengthened when combined with ADC value.
3. Using the above technique is nearly replacing 
the need intravenous contrast administration, 
especially in renal disease and when the 
contrast is not available.
4. DWI and ADC are beneficial in follow-up of 
previously detected restricted lesion and in 
assessment lesions response to the treatment.
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